Examining the Validity and Reliability of the Dresden Falls Questionnaire in Patients With Parkinson's Diagnosis Living in Turkey

NCT06630026 | Completed DMC

• 1 other identifier: 2024/115 DREFAQ
• Study Type: observational
• Target: 64
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to adapt the Dresden Falls Questionnaire scale (DREFAQ) to Turkish society and to make its validity and reliability in Turkish. The DREFAQ) scale developed by Frank, Anika, et al assesses falls in patients with Parkinson. It has 5 questions. This study will be conducted with Parkinson patients. The patients will be sought to answer questionnaires during regular rehabilitation sessions. 50 participants will be included in the study. In order to evaluate the validity of the DREFAQ, the Modified Falls Efficacy Scale (MFES), which can evaluate the efficacy of falls and has been validated in Turkish, and the Parkinson's Disease Quality of Life (PDQOL) questionnaire, which can evaluate the quality of life and has been validated in Turkish, will be used. Scales will be repeated after 15 days to assess test-retest reliability.

Conditions

Parkinson Disease; Falls; Scale Reliability Validity

Keywords

Parkinson disease; Falls; Scale reliability validity

Outcome Measures

Primary Outcomes (2)

• Falls

  Falls will be assessed with the Dresden Falls Questionnaire scale (DREFAQ). DREFAQ consists of 5 items in total. Items 1 to 4 are scored from 0 to 3. The total score of the DREFAQ is calculated by summing the first 4 items (0-12). The location of the injury (from item 4) and the circumstances (item 5) are not used in the score calculation but provide additional qualitative information. Higher scores indicate a high risk of falling.

  Baseline

• Falls Efficacy

  Falls efficacy will be assessed with the Modified Falls Efficacy Scale (MFES) scale. The MFES consists of 14 items in total. Items are scored from 0 (not sure of himself/herself) to 10 (totally confident). Total score is between 0-140. Lower scores indicate a high risk of falling.

  Baseline

Secondary Outcomes (1)

• Health-Related Quality of Life (HRQoL)

  Baseline

Study Arms (1)

Parkinson Patients

Parkinson patients who are aged 18-80 years with Hoehn \& Yahr scale between 1-4 and able to speak and read Turkish, will recruit to the study.

Other: The aim of this study is to adapt the Dresden Falls Questionnaire scale (DREFAQ)scale to Turkish society in Parkinson patients and to make its validity and reliability in Turkish.

Interventions

The aim of this study is to adapt the Dresden Falls Questionnaire scale (DREFAQ)scale to Turkish society in Parkinson patients and to make its validity and reliability in Turkish. OTHER

• The aim of this study is to adapt the Dresden Falls Questionnaire scale (DREFAQ)scale to Turkish society and to make its validity and reliability in Turkish. It has 5 questions. This study will be conducted with Parkinson patients. The patients will be sought to answer questionnaires during regular rehabilitation sessions.

Parkinson Patients

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Parkinson patients who are aged 18-80 years with Hoehn \& Yahr score between 1-4 and able to speak and read Turkish.

You may qualify if:

• Individuals with a Hoehn \& Yahr score between 1-4,
• Individuals who can ambulate with or without assistive equipment,
• Individuals with a Mini Mental State Examination score of \>24,
• Individuals with a history of falling at least once in the last year,

You may not qualify if:

• communication or cognitive problems,
• aphasia and speech disorders
• unstable medical conditions

Sponsors & Collaborators

• Istanbul Medeniyet University: lead

Study Sites (1)

İstanbul Medeniyet University

Istanbul, 34720, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian Disorders; Basal Ganglia Diseases; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Movement Disorders; Synucleinopathies; Neurodegenerative Diseases

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Target Duration: 15 Days
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: PhD Research Assistant

Study Record Dates

• First Submitted: October 4, 2024
• First Posted: October 8, 2024
• Study Start: October 15, 2024
• Primary Completion: December 15, 2024
• Study Completion: March 30, 2025
• Last Updated: September 2, 2025

Record last verified: 2025-08

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)